Enovis

Yahoo Finance • 22 days ago

ENOV Q3 Deep Dive: Portfolio Streamlining and Innovation Drive Amid Margin Headwinds

Medical technology company Enovis Corporation (NYSE:ENOV) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.6% year on year to $548.9 million. The company expects the full year’s revenue to be around $2.26 b... Full story

Yahoo Finance • 22 days ago

Enovis raises 2025 adjusted EPS guidance to $3.10–$3.25 while sharpening portfolio focus

Earnings Call Insights: Enovis Corporation (ENOV) Q3 2025 MANAGEMENT VIEW * CEO Damien McDonald highlighted the company's "solid third quarter results reflect strong performance broadly across the portfolio as we increasingly focus on... Full story

Yahoo Finance • 23 days ago

Enovis Corporation beats top-line and bottom-line estimates; updates FY25 outlook

* Enovis Corporation press release [https://seekingalpha.com/pr/20296140-enovis-announces-third-quarter-2025-results] (ENOV [https://seekingalpha.com/symbol/ENOV]): Q3 Non-GAAP EPS of $0.75 beats by $0.10. * Revenue of $549M (+8.7% Y/Y... Full story

Yahoo Finance • 23 days ago

Enovis Announces Third Quarter 2025 Results

Diversified growth platform delivers third-quarter sales growth of 9% on a reported basis, 7% organically Third-quarter Reconstructive sales grew 12% year-over-year on a reported basis, 9% organically October divestiture of Diabetic Foot... Full story

Yahoo Finance • 23 days ago

Diamond Hill Capital's Strategic Moves: A Closer Look at Zoetis Inc.

This article first appeared on GuruFocus. Exploring Diamond Hill Capital (Trades, Portfolio)'s Latest 13F Filing for Q3 2025 Warning! GuruFocus has detected 4 Warning Sign with AIG. Is AIG fairly valued? Test your thesis with our free DC... Full story

Mentioned:

ABT
AIG
BRK.B
CL
COF
DHIL
FDX
IXIC

Yahoo Finance • 24 days ago

Enovis Corporation Q3 2025 Earnings Preview

* Enovis Corporation (ENOV [https://seekingalpha.com/symbol/ENOV]) is scheduled to announce Q3 earnings results on Thursday, November 6th, before market open. The consensus EPS Estimate is $0.65 [https://seekingalpha.com/symbol/ENOV/earn... Full story

Yahoo Finance • last month

Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences

Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, announced today it will host an investor conference call and live webcas... Full story

Yahoo Finance • 2 months ago

13 Top Stocks With Huge Upside Potential To Buy Now

Buying stocks when the market is setting all-time highs can be a bit nerve-wracking. On the one hand, markets often continue to make new highs once they break through to new records. Conversely, nothing goes up in a straight line. After ba... Full story

Mentioned:

Yahoo Finance • 2 months ago

Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Mentioned:

CNMD
IART
INSP
MMSI

Yahoo Finance • 2 months ago

Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million

Wilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced the sale of its Dr. Comfort diabetic shoe business t... Full story

Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences... Full story

Yahoo Finance • 4 months ago

Enovis raises 2025 revenue guidance to $2.275B amid CEO transition and product momentum

Earnings Call Insights: Enovis Corporation (ENOV) Q2 2025 MANAGEMENT VIEW * Damien McDonald, in his first earnings call as CEO, emphasized his commitment to shareholders and outlined a multiyear roadmap focused on "profitable, capital-... Full story

Mentioned:

NVDA

Yahoo Finance • 4 months ago

Enovis Corp (NYSE:ENOV) Reports Mixed Q2 2025 Results with EPS Beat and Revenue Miss

Enovis Corp (NYSE:ENOV [https://www.chartmill.com/stock/quote/ENOV/profile]) reported its second-quarter 2025 financial results, delivering mixed performance relative to analyst expectations. The medical technology company posted revenue o... Full story

Yahoo Finance • 4 months ago

Enovis Q2 2025 slides: Revenue and EPS growth accelerate, guidance raised

Introduction & Market Context Enovis Corporation (NYSE:ENOV) released its second quarter 2025 results on August 7, showing accelerated growth and improved profitability that prompted management to raise full-year guidance. The medical tec... Full story

Mentioned:

Yahoo Finance • 4 months ago

Enovis Announces Second Quarter 2025 Results

Continued commercial momentum with second-quarter sales growth of 7% on a reported basis Second-quarter Reconstructive sales grew 11% year-over-year on a reported basis Wilmington, DE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporat... Full story